Ditchcarbon
  • Contact
  1. Organizations
  2. Shilpa Medicare
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 2 months ago

Shilpa Medicare Sustainability Profile

Company website

Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.

DitchCarbon Score

How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Shilpa Medicare's score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.

40%

Let us know if this data was useful to you

Shilpa Medicare's reported carbon emissions

In 2024, Shilpa Medicare reported total carbon emissions of approximately 24,892,210 kg CO2e, comprising about 3,690,310 kg CO2e from Scope 1 and about 20,389,900 kg CO2e from Scope 2 emissions. In the previous year, 2023, the company recorded emissions of about 16,220,940 kg CO2e, with Scope 1 emissions at approximately 1,523,280 kg CO2e and Scope 2 emissions at about 14,691,660 kg CO2e. Shilpa Medicare has set ambitious climate commitments, aiming to achieve 100% renewable energy usage by 2030 and to become a net-zero carbon company by 2050. These targets encompass all scopes of emissions, reflecting a long-term strategy to lead the energy transition. The company has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. Overall, Shilpa Medicare's commitment to sustainability and carbon reduction aligns with industry standards and reflects a proactive approach to climate change mitigation.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
1,523,280
0,000,000
0,000,000
Scope 2
14,691,660
00,000,000
00,000,000
Scope 3
877,770
-
-

How Carbon Intensive is Shilpa Medicare's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shilpa Medicare's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Shilpa Medicare's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Shilpa Medicare is in IN, which has a very high grid carbon intensity relative to other regions.

Shilpa Medicare's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Shilpa Medicare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Shilpa Medicare's Emissions with Industry Peers

Aurobindo Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

Dishman Pharmaceuticals and Chemicals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Suven Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251125.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy